Opportunities for process analytical technology integration in the QbD framework for vaccine formulation development and manufacturing
Conference Dates
May 19 - 24, 2024
Abstract
Please click Additional Files below to see the full abstract.
Recommended Citation
Nausheen Rahman, Kirsten Strahlendorf, and Chrisford Ling, "Opportunities for process analytical technology integration in the QbD framework for vaccine formulation development and manufacturing" in "Vaccine Technology IX", Linda Lua, The University of Queensland, Australia; Charles Lutsch, Sanofi-Vaccines, France; Francesc Gòdia, Universitat Autònoma de Barcelona (UAB), Spain; Tara Tagmyer, CMC Leader, USA Eds, ECI Symposium Series, (2024). https://dc.engconfintl.org/vaccine_ix/13
97.pdf (103 kB)
COinS